Alison Elizabeth Trimby, LICSW Clinical Social Worker Medicare: Not Enrolled in Medicare Practice Location: 203 Willow St Ste 3, South Hamilton, MA 01982 Phone: 978-712-0299 Fax: 844-640-9919 |
Ms. Maryellen Fairchild Collamore, LICSW, LCSW, MT-BC Clinical Social Worker Medicare: Medicare Enrolled Practice Location: 380 Highland St, South Hamilton, MA 01982 Phone: 978-233-1226 |
Caroline S Harris, MSW Clinical Social Worker Medicare: Medicare Enrolled Practice Location: 22 Aj Gordon Ct # B205, South Hamilton, MA 01982 Phone: 336-905-2006 |
Kathleen M Lyons, LICSW Clinical Social Worker Medicare: Accepting Medicare Assignments Practice Location: 205 Willow St Bldg B, South Hamilton, MA 01982 Phone: 978-572-0788 Fax: 844-222-4840 |
Patricia Axsom O'brien, M.DIV., LICSW Clinical Social Worker Medicare: Not Enrolled in Medicare Practice Location: 639 Bay Rd, South Hamilton, MA 01982 Phone: 978-309-9660 |
Ms. Jessica Hammon Webb, LICSW Clinical Social Worker Medicare: Accepting Medicare Assignments Practice Location: 205 Willow St Ste B3f, South Hamilton, MA 01982 Phone: 978-239-7633 |
Mr. Robert Kaufman, MSW Clinical Social Worker Medicare: Not Enrolled in Medicare Practice Location: 60 Railroad Ave, South Hamilton, MA 01982 Phone: 978-468-7010 |
News Archive
An experimental vaccine to prevent Ebola virus disease was well-tolerated and produced immune system responses in all 20 healthy adults who received it in a Phase 1 clinical trial conducted by researchers from the National Institutes of Health. The candidate vaccine, which was co-developed by the NIH's National Institute of Allergy and Infectious Diseases and GlaxoSmithKline, was tested at the NIH Clinical Center in Bethesda, Maryland.
New research indicates that the benefits of a dietary compound on kidney health may depend on an individual's genetics. The findings, which appear in an upcoming issue of JASN, may be helpful for tailoring interventions to prevent or treat kidney disease.
As the novel coronavirus pandemic sweeps the globe, contact tracing has taken the spotlight as epidemiologists scramble to identify and isolate potential vectors for the disease. Limited technology has forced authorities to fall back on manual methods, which are both time-consuming and limited in reliability since they depend on the ability of the infected individual to remember all the places and persons he/she has been in contact with.
AVEO Oncology and Astellas Pharma Global Development, Inc., a U.S. subsidiary of Tokyo-based Astellas Pharma Inc., today announced that the U.S. Food and Drug Administration's Oncologic Drugs Advisory Committee will review the company's New Drug Application for tivozanib for the treatment of patients with advanced renal cell carcinoma during the morning session of its meeting on May 2, 2013.
› Verified 3 days ago